Welcome to LookChem.com Sign In|Join Free
  • or
Acetamide, N-[4-[[[2-(4-pyridinylcarbonyl)phenyl]amino]sulfonyl]phenyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

827575-89-3

Post Buying Request

827575-89-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

827575-89-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 827575-89-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,7,5,7 and 5 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 827575-89:
(8*8)+(7*2)+(6*7)+(5*5)+(4*7)+(3*5)+(2*8)+(1*9)=213
213 % 10 = 3
So 827575-89-3 is a valid CAS Registry Number.

827575-89-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name N-[4-[[2-(pyridine-4-carbonyl)phenyl]sulfamoyl]phenyl]acetamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:827575-89-3 SDS

827575-89-3Downstream Products

827575-89-3Relevant academic research and scientific papers

2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists

Su, Dai-Shi,Lim, John L.,Tinney, Elizabeth,Wan, Bang-Lin,Murphy, Kathy L.,Reiss, Duane R.,Harrell, C. Meacham,O'Malley, Stacy S.,Ransom, Rick W.,Chang, Raymond S. L.,Pettibone, Douglas J.,Yu, Jian,Tang, Cuyue,Prueksaritanont, Thomayant,Freidinger, Roger M.,Bock, Mark G.,Anthony, Neville J.

experimental part, p. 3946 - 3952 (2009/05/11)

Selective bradykinin (BK) B1 receptor antagonists could be novel therapeutic agents for the treatment of pain and inflammation. Elucidation of the structure activity relationships of the structurally novel HTS lead compound 1 provided potent hBK B1 receptor antagonists with excellent receptor occupancy in the CNS of hBK B1 transgenic rats.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 827575-89-3